His primary areas of study are Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort study and Cohort. David Rimland combines subjects such as Coinfection, Surgery and Hepatitis C virus with his study of Internal medicine. His research integrates issues of Young adult and Case-control study in his study of Immunology.
The concepts of his Acquired immunodeficiency syndrome study are interwoven with issues in Epidemiology, Gerontology, Confidence interval, Essential hypertension and Depression. His Cohort study research includes themes of Prospective cohort study, Proportional hazards model and Myocardial infarction. His studies deal with areas such as Psychological intervention, Incidence, Medical record, Alcohol abuse and Hazard ratio as well as Cohort.
His scientific interests lie mostly in Internal medicine, Cohort study, Immunology, Acquired immunodeficiency syndrome and Cohort. His research is interdisciplinary, bridging the disciplines of Surgery and Internal medicine. The various areas that David Rimland examines in his Cohort study study include Gerontology, Confidence interval, Proportional hazards model, Prospective cohort study and Comorbidity.
In his research on the topic of Immunology, Opportunistic infection is strongly related with Pneumonia. Within one scientific family, David Rimland focuses on topics pertaining to Viral disease under Acquired immunodeficiency syndrome, and may sometimes address concerns connected to Immunopathology. David Rimland works mostly in the field of Cohort, limiting it down to topics relating to Incidence and, in certain cases, Pediatrics.
David Rimland mainly investigates Internal medicine, Cohort study, Cohort, Immunology and Veterans Affairs. His Cohort study research includes elements of Odds ratio, Physical therapy, Incidence, Gerontology and Prospective cohort study. His Prospective cohort study research focuses on subjects like Acquired immunodeficiency syndrome, which are linked to Cancer and Absolute risk reduction.
David Rimland has included themes like Viremia, Viral load, Cancer registry, Disease and Seroconversion in his Cohort study. His study in Immunology is interdisciplinary in nature, drawing from both Biomarker, Alanine transaminase and Pneumonia. His Veterans Affairs study incorporates themes from Vitamin D and neurology, vitamin D deficiency and Risk of mortality.
Internal medicine, Cohort study, Cohort, Hazard ratio and Immunology are his primary areas of study. His research brings together the fields of Viral load and Internal medicine. His work deals with themes such as Incidence, Myocardial infarction, Hiv infected, Physical therapy and Risk factor, which intersect with Cohort study.
His Cohort research incorporates elements of Rate ratio, Hepatitis C and Seroconversion. His work deals with themes such as Biomarker and Absolute risk reduction, which intersect with Immunology. His work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Circulating MicroRNA and Case-control study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
HIV Infection and the Risk of Acute Myocardial Infarction
Matthew S. Freiberg;Chung Chou H Chang;Lewis H. Kuller;Melissa Skanderson.
JAMA Internal Medicine (2013)
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg.
Clinical Infectious Diseases (1995)
The Changing Epidemiology of Cryptococcosis: An Update from Population-Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000
Sara A. Mirza;Maureen Phelan;David Rimland;David Rimland;Edward A. Graviss.
Clinical Infectious Diseases (2003)
RAPID DEVELOPMENT OF CIPROFLOXACIN RESISTANCE IN METHICILLIN-SUSCEPTIBLE AND -RESISTANT STAPHYLOCOCCUS AUREUS
H M Blumberg;D Rimland;D J Carroll;P Terry.
The Journal of Infectious Diseases (1991)
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era
Kristina Crothers;Laurence Huang;Joseph L. Goulet;Matthew Bidwell Goetz.
American Journal of Respiratory and Critical Care Medicine (2011)
Do Patterns of Comorbidity Vary by HIV Status, Age, and HIV Severity?
Joseph L. Goulet;Shawn L. Fultz;David Rimland;Adeel Butt.
Clinical Infectious Diseases (2007)
Hepatitis C in the HIV (Human Immunodeficiency Virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The Effect of Coinfection on Survival
C. T. Staples;D. Rimland;D. Dudas.
Clinical Infectious Diseases (1999)
Outbreak of Clostridium difficile Infection in a Long-Term Care Facility: Association with Gatifloxacin Use
Robert Gaynes;Robert Gaynes;David Rimland;David Rimland;Edna Killum;H. Ken Lowery.
Clinical Infectious Diseases (2004)
Veterans Aging Cohort Study (VACS): Overview and description.
Amy C. Justice;Elizabeth Dombrowski;Joseph Conigliaro;Shawn L. Fultz.
Medical Care (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Yale University
Baylor College of Medicine
Hamad Medical Corporation
University of California, Los Angeles
Yale University
Emory University
UCLA Medical Center
University of California, San Francisco
Rutgers, The State University of New Jersey
New York University
University of Melbourne
Boise State University
Optum (United States)
Sandia National Laboratories
University of Montreal
San Diego State University
University of Edinburgh
University of Natural Resources and Life Sciences
Juntendo University
University of California, Irvine
Columbia University
Tokai University
Mayo Clinic
National Academies of Sciences, Engineering, and Medicine
University of Colorado Denver
University of Toronto